Cancer
Nutrition and Cancer 101 – The Basics
Patient Worthy is honored to reprint this selection from The Cancer Dietitian, by Julie Lanford MPH, RD, CSO, LDN. It’s important to know that no single
Jade Biosciences Initiates Phase 2 Trial of JADE101 in IgA Nephropathy
- May 30, 2026
Epidermolysis Bullosa Care Enters a New Era With Gene-Targeted and Wound-Healing Therapies
Biogen–Denali Parkinson’s Therapy Falters in Mid-Stage Trial, Shifting Focus to Targeted Subgroups
Caplyta Gains FDA Approval for Schizophrenia Relapse Prevention with Significant Clinical Benefit
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
Crohn's disease
Fighting for Himself and Others: Wojciech’s Battle Against Crohn’s Disease and More
I am sharing my journey to give a voice to patients who suffer from extreme poly-pathology and are often left behind by the medical system.
Colorectal cancer
Pre-Surgery Immunotherapy Rewrites Colorectal Cancer Survival: Zero Recurrence at Three Years
For decades, colorectal cancer treatment has followed the same playbook: surgeons remove the tumor, then patients endure months of chemotherapy hoping to catch any remaining
Parkinson's Disease
AskBio Advances Parkinson’s Gene Therapy Program With Commercial-Scale Manufacturing
AskBio Inc., a gene therapy company operating independently under Bayer AG, has taken a key step forward in the development of its investigational Parkinson’s disease
Lupus
Dismissal, Derision, and Misdiagnosis: Olga’s Lupus Story
Editor’s Note: This story was originally published on Linked-In and is shared with permission by Olga Lucia Torres. In college, a clinician told me I
Lupus
Breaking Ground: New Targeted Lupus Treatment Enters Critical Phase 3 Testing
Enpatoran offers hope for millions suffering from lupus skin manifestations Pharmaceutical company Merck KGaA has announced a significant milestone in lupus treatment research. As reported
Obesity
Vanda Initiates Thetis Trial to Address GLP‑1–Related Vomiting
As reported on PharmaBiz, Vanda Pharmaceuticals has launched a new clinical trial, known as Thetis, to evaluate whether its neurokinin‑1 (NK‑1) receptor antagonist Nereus (tradipitant)
Pancreatic Cancer
After Losing His Mother to Pancreatic Neuroendocrine Tumors, Michael Fitzpatrick Is Now a 26-Year Survivor of the Same Condition
Editor’s Note: Patient Worthy is honored to present this article, shared with us by our friends at the Seena Magowitz Foundation. When doctors diagnosed Michael
Epidermolysis Bullosa
Ireland Embraces Hope: Revolutionary EB Gel Treatment Now Available Through HSE
A major breakthrough for the 300 Irish patients living with butterfly skin. For the first time in Ireland, patients battling epidermolysis bullosa, a rare and
Rare Disease
Two Mothers. One Trial. Two Different Outcomes: A Mother’s Day Reflection from Clinical Research
Editor’s Note: Patient Worthy is honored to share this story submitted to us by Regina Portnoy, a clinical researcher with over 20 years of experience.
Osteosarcoma
The Timeless Passages of My Mind and Soul
Editor’s Note: Patient Worthy is honored to share this patient story from our friends at Elephants & Tea. To see the story in its original
Rare Disease
Topical Curcumin Gel Shows Promise for Knee Osteoarthritis Pain in Early Clinical Trial
As shared on drugs.com, Vascarta Inc. has reported encouraging results from a Phase 1b clinical study evaluating its investigational topical/transdermal curcumin gel, VAS-101, for the
Generalized arterial calcification of infancy-1 (GACI1)
Sir’Savion’s Story
Editor’s Note: Patient Worthy is honored to share this article from our friends at the Brighter Hope Foundation. To see the article in its original
Ovarian Cancer
Labcorp Brings Breakthrough Diagnostic to Identify Platinum-Resistant Ovarian Cancer Patients
Labcorp announced the nationwide availability of Agilent Technologies’ PD-L1 IHC 22C3 pharmDx, the only FDA-approved companion diagnostic designed to identify patients with platinum-resistant ovarian cancer
Pancreatic Cancer
Daraxonrasib Delivers Landmark Survival Gains in Previously Treated Metastatic Pancreatic Cancer
As reported on drugs.com, Revolution Medicines has reported practice-changing efficacy results from a pivotal Phase 3 trial evaluating daraxonrasib in patients with metastatic pancreatic ductal
Primary Biliary Cholangitis
The PBCers Conference
This, year the PCBers will meet in Indianapolis, Indiana. They will be celebrating 30 years as a community, as well as celebrating a much brighter
Autoimmune hemolytic anemia
FDA Priority Review Accelerates Path for IMAAVY as First Treatment for Warm Autoimmune Hemolytic Anemia
Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to IMAAVY® (nipocalimab-aahu), marking a significant milestone as the
Atopic dermatitis
Enveda’s Oral Candidate ENV-294 Shows Early Promise in Atopic Dermatitis
As reported on Business Wire, Enveda, a clinical-stage biotechnology company focused on discovering novel small-molecule medicines, has reported encouraging results from a Phase 1b study
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
May 30 is World MS Day🧡
A day to bring awareness to multiple sclerosis, a chronic disease that affects the central nervous system and can impact mobility, energy, and daily life. Millions of people worldwide are living with MS, and many face challenges in receiving a timely diagnosis and proper support.
By raising awareness, we can help improve understanding, encourage early diagnosis, and support those navigating life with MS. Take a moment to learn more, share resources, and show support for the MS community. 🧡
#WorldMSDay #msawareness #MultipleSclerosis #PatientWorthy
Huntington's disease affects far more than movement alone- it can impact emotions, memory, thinking, and entire families across generations. Raising awareness about the importance of early recognition, genetic counseling, and continued research helps create space for understanding, support, and hope for those navigating this complex neurological condition. Every conversation shared brings us one step closer to greater compassion and future breakthroughs. Click the link to share today! bit.ly/3VuxFDV
#HDAwareness #neurologicadisorders #PatientWorthy
Mission: Cure chronic pancretitis
